RedHill grows revenue in third quarter, closes public offering

After reporting initial net revenues of $500,000 for the period between June 12 and June 30 following the start of U.S. promotional activities for a pair of gastrointestinal products, RedHill Biopharma (Nasdaq: RDHL) reported revenues of $1.5 million for the third quarter.   According to Tel-Aviv-based RedHill – which opened an office in Raleigh earlier this year with a number of former Salix employees to serve as its head of U.S. commercial operations – its third quarter revenue is from its…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news